BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo AJ, Tan J, He LY, Jiang XZ, Jiang ZQ, Zeng Q, Yao K, Xue J. Suppression of Tescalcin inhibits growth and metastasis in renal cell carcinoma via downregulating NHE1 and NF-kB signaling. Exp Mol Pathol. 2019;107:110-117. [PMID: 30594602 DOI: 10.1016/j.yexmp.2018.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Becker F, Fuchs S, Refisch L, Drepper F, Bildl W, Schulte U, Liang S, Heinicke JI, Hansen SC, Kreutz C, Warscheid B, Fakler B, Mymrikov EV, Hunte C. Conformational dynamics and target-dependent myristoyl switch of calcineurin B homologous protein 3.. [DOI: 10.1101/2022.09.23.509142] [Reference Citation Analysis]
2 Fan Y, Fan X, Yan H, Liu Z, Wang X, Yuan Q, Xie J, Lu X, Yang Y. Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis. Cell Death Dis 2022;13:157. [DOI: 10.1038/s41419-021-04210-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Huang T, Tian W, Zhou Q, Li J, Jiang Z, Chen J, Ge C, Tian H. Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma. Acta Biochim Biophys Sin (Shanghai) 2021;53:988-96. [PMID: 34133712 DOI: 10.1093/abbs/gmab078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhang R, Yang F, Fan H, Wang H, Wang Q, Yang J, Song T. Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway. Cell Death Dis 2021;12:524. [PMID: 34021124 DOI: 10.1038/s41419-021-03812-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
5 Hsieh CH, Chu CY, Lin SE, Yang YSH, Chang HS, Yen Y. TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma. Cancers (Basel) 2020;12:E1105. [PMID: 32365487 DOI: 10.3390/cancers12051105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
6 Mehrgou A, Ebadollahi S, Jameie B, Teimourian S. Analysis of subtype-specific and common Gene/MiRNA expression profiles of four main breast cancer subtypes using bioinformatic approach; Characterization of four genes, and two MicroRNAs with possible diagnostic and prognostic values. Informatics in Medicine Unlocked 2020;20:100425. [DOI: 10.1016/j.imu.2020.100425] [Reference Citation Analysis]
7 Anderson KJ, Cormier RT, Scott PM. Role of ion channels in gastrointestinal cancer. World J Gastroenterol 2019; 25(38): 5732-5772 [PMID: 31636470 DOI: 10.3748/wjg.v25.i38.5732] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 82] [Article Influence: 26.0] [Reference Citation Analysis]
8 Yang K, Xiao Y, Xu T, Yu W, Ruan Y, Luo P, Cheng F. Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis. Cancer Gene Ther 2020;27:607-18. [PMID: 31570754 DOI: 10.1038/s41417-019-0138-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]